Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-21 Sale |
2022-01-12 10:07 am |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
14,949 | $2.49 | $37,223 | 92,410 (Direct) |
View |
2021-04-21 Sale |
2021-04-23 4:30 pm |
HOOKIPA Pharma Inc. | HOOK | SOFINNOVA CAPITAL VI FCPR Sofinnova Partners SAS 10% Owner |
328,620 | $11.6 | $3,812,386 | 3,177,574 (Direct) |
View |
2021-03-29 Sale |
2021-03-31 4:06 pm |
HOOKIPA Pharma Inc. | HOOK | SOFINNOVA CAPITAL VI FCPR Sofinnova Partners SAS 10% Owner |
36,829 | $13.67 | $503,570 | 3,506,194 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-30 Option Award |
2022-07-01 4:13 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer |
48,350 | $0 | 48,350 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:12 pm |
N/A 2032-06-30 |
HOOKIPA Pharma Inc. | HOOK | O'Neill Julie Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:11 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Necina Roman Chief Technology Officer |
48,350 | $0 | 48,350 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:11 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
92,950 | $0 | 92,950 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:09 pm |
N/A 2032-06-30 |
HOOKIPA Pharma Inc. | HOOK | Kelly Michael Aaron Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:08 pm |
N/A 2032-06-30 |
HOOKIPA Pharma Inc. | HOOK | Kaufman David Ross Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:07 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Kandera Reinhard Chief Financial Officer |
92,950 | $0 | 92,950 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:06 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Baker Christine D. Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:05 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Aldag Jorn Chief Executive Officer |
275,250 | $0 | 275,250 (Direct) |
View |
2022-04-19 Option Award |
2022-04-20 4:30 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer |
48,350 | $0 | 48,350 (Direct) |
View |
2022-04-19 Option Award |
2022-04-20 4:29 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Necina Roman Chief Technology Officer |
48,350 | $0 | 48,350 (Direct) |
View |
2022-04-19 Option Award |
2022-04-20 4:27 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
92,950 | $0 | 92,950 (Direct) |
View |
2022-04-19 Option Award |
2022-04-20 4:26 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Kandera Reinhard Chief Financial Officer |
92,950 | $0 | 92,950 (Direct) |
View |
2022-04-19 Option Award |
2022-04-20 4:25 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Baker Christine D. Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2022-04-19 Option Award |
2022-04-20 4:24 pm |
N/A 2032-04-19 |
HOOKIPA Pharma Inc. | HOOK | Aldag Jorn Chief Executive Officer |
275,250 | $0 | 275,250 (Direct) |
View |
Ownership |
2022-02-17 2:45 pm |
N/A N/A |
HOOKIPA Pharma Inc. | HOOK | GILEAD SCIENCES INC 10% Owner |
0 | $0 | 3,759,465 (Direct) |
View |
2022-02-01 Option Award |
2022-02-01 8:52 pm |
N/A 2032-01-31 |
HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Executive VP, Research |
21,842 | $3 | 23,058 (Direct) |
View |
2022-02-01 Option Award |
2022-02-01 8:50 pm |
N/A 2032-01-31 |
HOOKIPA Pharma Inc. | HOOK | Baker Christine D. Chief Business Officer |
36,421 | $3 | 38,921 (Direct) |
View |
2022-02-01 Option Award |
2022-02-01 8:50 pm |
N/A 2032-01-31 |
HOOKIPA Pharma Inc. | HOOK | Necina Roman Chief Technology Officer |
34,378 | $3 | 36,362 (Direct) |
View |
2022-02-01 Option Award |
2022-02-01 8:49 pm |
N/A 2032-01-31 |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
39,821 | $3 | 125,128 (Direct) |
View |
2022-02-01 Option Award |
2022-02-01 8:48 pm |
N/A 2032-01-31 |
HOOKIPA Pharma Inc. | HOOK | Kandera Reinhard Chief Financial Officer |
37,483 | $3 | 39,519 (Direct) |
View |
2022-02-01 Option Award |
2022-02-01 8:44 pm |
N/A 2032-01-31 |
HOOKIPA Pharma Inc. | HOOK | Aldag Jorn Chief Executive Officer |
87,677 | $3 | 91,805 (Direct) |
View |
2021-12-21 Exercise |
2022-01-12 10:07 am |
N/A N/A |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
22,853 | $0.1 | 92,410 (Direct) |
View |
2021-12-21 Exercise |
2022-01-12 10:07 am |
N/A 2026-12-31 |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
22,853 | $0 | 92,410 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:38 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | van de Winkel Jan Director |
19,200 | $0 | 19,200 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:37 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | Soria Jean-Charles Director |
9,600 | $0 | 9,600 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:37 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | Seghezzi Graziano Director |
9,600 | $0 | 9,600 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:36 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | O'Neill Julie Director |
9,600 | $0 | 9,600 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:35 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | Lengauer Christoph Director |
9,600 | $0 | 9,600 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:34 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | Kelly Michael Aaron Director |
9,600 | $0 | 9,600 (Direct) |
View |
2021-06-01 Option Award |
2021-06-04 8:33 pm |
N/A 2031-06-01 |
HOOKIPA Pharma Inc. | HOOK | Kaufman David Ross Director |
9,600 | $0 | 9,600 (Direct) |
View |
2021-04-19 Option Award |
2021-04-21 4:40 pm |
N/A 2031-04-19 |
HOOKIPA Pharma Inc. | HOOK | Necina Roman Chief Technology Officer |
36,750 | $0 | 36,750 (Direct) |
View |
2021-04-19 Option Award |
2021-04-21 4:38 pm |
N/A 2031-04-19 |
HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research |
26,050 | $0 | 26,050 (Direct) |
View |
2021-04-19 Option Award |
2021-04-21 4:37 pm |
N/A 2031-04-19 |
HOOKIPA Pharma Inc. | HOOK | Baker Christine D. Chief Business Officer |
49,950 | $0 | 49,950 (Direct) |
View |
2021-04-19 Option Award |
2021-04-21 4:36 pm |
N/A 2031-04-19 |
HOOKIPA Pharma Inc. | HOOK | Matushansky Igor Chief Medical Officer |
95,250 | $0 | 95,250 (Direct) |
View |
2021-04-19 Option Award |
2021-04-21 4:34 pm |
N/A 2031-04-19 |
HOOKIPA Pharma Inc. | HOOK | Kandera Reinhard Chief Financial Officer |
69,300 | $0 | 69,300 (Direct) |
View |
2021-04-19 Option Award |
2021-04-21 4:31 pm |
N/A 2031-04-19 |
HOOKIPA Pharma Inc. | HOOK | Aldag Jorn Chief Executive Officer |
207,600 | $0 | 207,600 (Direct) |
View |